MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment

This publication has 58 references indexed in Scilit:

• Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction
  The Journal of Pathology, 2012
• Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function
  Proceedings of the National Academy of Sciences, 2011
• Effect of hydrogen sulfide on intracellular calcium homeostasis in neuronal cells
  Neurochemistry International, 2010
• Hydrogen sulfide is an endogenous stimulator of angiogenesis
  Proceedings of the National Academy of Sciences, 2009
• Preeclampsia and Soluble fms-Like Tyrosine Kinase 1
  The Journal of Clinical Endocrinology & Metabolism, 2009
• Pharmacological profile of a novel H2S-releasing aspirin
  Free Radical Biology and Medicine, 2009
• Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
  BMJ, 2007
• Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function
  Proceedings of the National Academy of Sciences, 2007
• Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation
  The FASEB Journal, 2006
• The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener
  The EMBO Journal, 2001